Trial of oral miltefosine for visceral leishmaniasis Academic Article uri icon

Overview

MeSH Major

  • Antiprotozoal Agents
  • Leishmaniasis, Visceral
  • Phosphorylcholine

abstract

  • Treatment with miltefosine at 100-150 mg/day for 4 weeks has promise as an effective oral treatment of visceral leishmaniasis including antimony-resistant infection.

publication date

  • December 5, 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9851383

Additional Document Info

start page

  • 1821

end page

  • 3

volume

  • 352

number

  • 9143